Amersham Biosciences and GeneBio Expand Alliance to Develop Next Generation Proteomics Image Analysis Software

Amersham Biosciences, the life sciences business of Amersham (LSE:, NYSE:, OSE: AHM) and Geneva Bioinformatics (GeneBio) S.A. have signed an exclusive agreement to provide researchers with the next generation of 2-D gel image analysis tools for proteomics research.

Please to read the entire article.

You must be logged in to post a comment Login